Johns Hopkins researchers describing this side effect in Neurology emphasized that Oxaliplatin clearly improves length of survival for advanced cancer patients by months to years.
They said the goal of their study is to find ways of preventing or slowing nerve damage through nerve-protective therapies identified through simple skin testing.
Related Articles on Colorectal Cancer:
Study: MRI Helps Predict Survival of Rectal Cancer Patients
Study: Just One Screening Reduces Colon Cancer Risk for Middle-Aged Patients
Study: Fecal Occult Blood Testing Effective for Colon Cancer Screening
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
